Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bundy, D A P
Right arrow Articles by de Silva, N R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bundy, D A P
Right arrow Articles by de Silva, N R
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 54:421-432 (1998)
© 1998 The British Council

research-article

Can we deworm this wormy world?

D A P Bundy and N R de Silva*

WHO Collaborating Centre for the Epidemiology of Intestinal Parasitic Infections, Welicome Trust Centre for the Epidemiology of Infectious Disease, University of Oxford Oxford, UK
*Present address: Department of Parasitology, Faculty of Medicine, University of Kelaniya Ragama, Sri Lanka

Correspondence to Prof D A P Bundy, WHO Collaborating Centre for the Epidemiology of Intestinal Parasitic Infections Wellcome Trust Centre for the Epidemiology of Infection Disease, University of Oxford South Parks Road, Oxford OX1 3PS, UK

Abstract

While programmes such as the Rockefeller campaign were specifically targeted at a particular parasite species, the current trend is towards the simultaneous control of all the major geohelminth species. New, broad-spectrum, low-cost anthelmintics and new understanding of epidemiology have led to more costeffective and sustainable strategies. The WHO, UNICEF and the World Bank all now support global and regional efforts to achieve control of morbidity from intestinal worms. In this paper, we aim to show what's new in clinical helminthology and what has brought about the great improvement in the success of the new approaches to control.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
G. Borkow and Z. Bentwich
Chronic Immune Activation Associated with Chronic Helminthic and Human Immunodeficiency Virus Infections: Role of Hyporesponsiveness and Anergy
Clin. Microbiol. Rev., October 1, 2004; 17(4): 1012 - 1030.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
S. Awasthi, D A P Bundy, and L. Savioli
Helminthic infections
BMJ, August 23, 2003; 327(7412): 431 - 433.
[Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
S. Geerts and B. Gryseels
Drug Resistance in Human Helminths: Current Situation and Lessons from Livestock
Clin. Microbiol. Rev., April 1, 2000; 13(2): 207 - 222.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Omura, H. Miyadera, H. Ui, K. Shiomi, Y. Yamaguchi, R. Masuma, T. Nagamitsu, D. Takano, T. Sunazuka, A. Harder, et al.
An anthelmintic compound, nafuredin, shows selective inhibition of complex I in helminth mitochondria
PNAS, January 2, 2001; 98(1): 60 - 62.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.